RECRUITING

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigator and study staff will identify, recruit and randomize Latina participants with elevated genetic and Social Determinants of Heath (SDH) risks. Within 1 week of enrollment, all Latina Aim 1 participants in both study arms will engage in three 30-minute, individual, phone-based sessions with the study team across 3 consecutive weeks

Official Title

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

Quick Facts

Study Start:2023-01-18
Study Completion:2027-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05483283

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. female biological sex
  2. 2. identification as Latina
  3. 3. one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
  4. 4. one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges)
  5. 5. 30+ years old, based on American Cancer Society (ACS) screening guidelines for high risk populations
  6. 6. No receipt of cancer genetic counseling AND no receipt of genetic testing
  7. 1. female biological sex
  8. 2. referral from Latina Aim 1 participants
  9. 3. eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual
  10. 4. screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older)
  11. 5. self-report not attending Session #3 (as this will not be recorded by the staff)
  12. 1. participant from Aim 1 or
  13. 2. participant from Aim 2
  1. 1. Not a participant from Aim 1 or
  2. 2. Not a participant from Aim 2

Contacts and Locations

Study Contact

Yamile Molina, PhD
CONTACT
312-355-2679
ymolin2@uic.edu

Study Locations (Sites)

University of Illinois
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: University of Illinois at Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-18
Study Completion Date2027-09

Study Record Updates

Study Start Date2023-01-18
Study Completion Date2027-09

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer